Tian J, Berton TR, Shirley SH, Lambertz I, Gimenez-Conti IB, DiGiovanni J, et al
Theres also a trend of greater benefit in physical functioning, body pain and general health domains with greater weight loss. Benefits with both drugs SURMOUNT-5 was a phase 3b randomized controlled open-label trial in which adults with obesity or overweight with at least one obesity-related comorbidity and at least one unsuccessful dietary attempt to lose weight were randomly assigned to once-weekly injectable semaglutide or tirzepatide for 72 weeks
These amounts rise to $16,100 for single filers and $32,200 for married joint filers in 2026 (applies to returns due April 15, 2027)
However, people who want to lose weight will spend money on GLP-1 medication
If you need a specific Ozempic dosage that falls outside the standard range, compounded semaglutide could be the right choice